Standards/gs1-datamatrix-pharma
GS1 DataMatrix Pharma
GS1 DataMatrix Pharma Serialization
Overview
GS1 DataMatrix Pharma Serialization is a data-format application, not a separate symbology. It is the use of the GS1 DataMatrix carrier — the ECC 200 variant of Data Matrix with a leading FNC1, carrying GS1 Application Identifier (AI) element strings — to mark each individual prescription-medicine pack with a unique identifier (UI) for anti-counterfeiting and traceability 2, 3. Two major regulatory regimes drive it: the EU Falsified Medicines Directive (FMD) and the US Drug Supply Chain Security Act (DSCSA) 1, 3.
The format is the same wherever it is applied: a single GS1 DataMatrix on the outer carton encodes four data elements — GTIN (AI 01), serial number (AI 21), batch/lot (AI 10), and expiry date (AI 17) — so that each saleable pack carries a globally unique, machine-readable identity that can be verified at the point of dispense 1, 3. This is not a new code: it is the standard GS1 DataMatrix profile applied to a regulated use case, with the same ISO/IEC 16022 ECC 200 encoding and FNC1 marker as any other GS1 DataMatrix 2.
History
EU Falsified Medicines Directive. The framework was established by Directive 2011/62/EU (the FMD), which amended Directive 2001/83/EC to require two safety features on prescription medicine packs: a machine-readable unique identifier and an anti-tampering device 1. The technical detail was set by Commission Delegated Regulation (EU) 2016/161, which became applicable on 9 February 2019 across the EU/EEA, mandating the GS1 DataMatrix carrier and the data elements of the unique identifier 1, 3.
US DSCSA. The Drug Supply Chain Security Act was enacted in 2013 as Title II of the Drug Quality and Security Act, building toward unit-level serialization and electronic, interoperable traceability across the US drug supply chain 3. Unit-level requirements were originally targeted for 2023, but the FDA granted a stabilization period, with enforcement phased through 2025: manufacturers and repackagers by 27 May 2025, wholesale distributors by 27 August 2025, and dispensers by 27 November 2025 3.
Technical specification
Carrier. The data carrier is a GS1 DataMatrix — ISO/IEC 16022 ECC 200 with a GS1 FNC1 in the first position to flag that the content is GS1 AI element strings, printed on the outer packaging with a human-readable text mirror of the data 2, 3. See GS1 DataMatrix and Data Matrix for the underlying symbology.
Encoded data elements. The unique identifier comprises four AI fields 1, 3:
| AI | Element | Notes |
|---|---|---|
01 |
GTIN | Product code (the marketing/identification number) |
21 |
Serial number | Randomized, unique per individual pack |
10 |
Batch / lot number | Manufacturing batch identifier |
17 |
Expiry date | Date format YYMMDD |
Under EU FMD, a national reimbursement / identification number may additionally be required by some member states 1, 3. The corresponding element string is of the form (01)…(21)…(10)…(17)…, encoded in the DataMatrix with FNC1 separators between variable-length fields 2, 3.
EU verification model. Each pack is checked against a repository system: the European Medicines Verification System (EMVS) federated with National Medicines Verification Systems (NMVS) 1, 3. At dispensing, the pharmacy scans the code, the system verifies authenticity, and the unique identifier is decommissioned so the serial cannot be reused by counterfeiters — Regulation (EU) 2016/161 requires "verification and subsequent decommissioning of the unique identifier of every supplied pack" 1.
US verification model. DSCSA does not prescribe a single barcode type but requires a serialized product identifier encoding at minimum the NDC (or equivalent standardized drug code), a randomized serial number, lot number, and expiration date; in practice this is carried in a GS1 DataMatrix (the GTIN being derived from the NDC) 3. DSCSA emphasizes electronic, interoperable data exchange between trading partners via EPCIS (Electronic Product Code Information Services) messages, rather than mandatory pharmacy-level verification at every dispense 3.
Use cases
- Anti-counterfeiting / authentication. The per-pack serial lets the supply chain detect falsified or duplicated packs at the point of dispense (EU FMD) 1, 3.
- Pharmacy dispensing. Scanning the GS1 DataMatrix verifies and decommissions the pack at the till in EU pharmacies 1.
- Traceability and recalls. GTIN + batch + serial enable recall and provenance actions at item or lot granularity across the supply chain 3, 4.
- Expiry management. The embedded expiry (AI
17) supports automated checks against dispensing expired stock 3.
Comparison
EU FMD vs US DSCSA. Both regimes require the same four core data elements (GTIN/NDC, serial, lot, expiry) and converge on the GS1 DataMatrix as carrier, but their architectures differ. EU FMD centres on point-of-dispense verification against centralized NMVS/EMVS repositories with mandatory decommissioning; DSCSA centres on transactional electronic data exchange (EPCIS) between trading partners and does not require pharmacy-level scanning of every pack — making the two complementary but structurally distinct 3.
GS1 DataMatrix vs GS1-128 for pharma. Some DSCSA logistics use cases use GS1-128 with SSCCs at the case/pallet level, but unit-level pack marking uses GS1 DataMatrix because the 2D matrix fits the four-AI unique identifier onto a small carton face where a linear symbol could not 2, 3.
Pharma DataMatrix vs retail Sunrise 2027. Healthcare serialization mandated GS1 DataMatrix at the item level years before retail's 2D transition; it is, in effect, the precedent the broader GS1 Sunrise 2027 retail program now follows, though retail additionally permits a GS1 QR Code carrying GS1 Digital Link URI syntax 2.
Status
GS1 DataMatrix pharma serialization is fully in force. EU FMD has been mandatory since 9 February 2019, with the EMVS connecting thousands of marketing-authorisation holders, wholesalers, and tens of thousands of pharmacies across the EU/EEA 1. US DSCSA unit-level serialization and interoperable traceability moved into enforcement through 2025 (manufacturers May 2025, wholesalers August 2025, dispensers November 2025) 3. More broadly, serialization on the GS1 DataMatrix model is mandated in dozens of countries worldwide 3.
Sources
1 FMD Explained: A Guide to Pharma Serialization & Barcodes — IntuitionLabs 2 GS1 DataMatrix — GS1 Standards — GS1 3 DSCSA vs. EU FMD: A Pharma Serialization & Traceability Guide — IntuitionLabs 4 Why GS1 Standards Are Transforming Healthcare Supply Chains — Dynamsoft
Deployments
No country reports mention this standard by name.
Regions / aggregations not mapped to a single country
- Universal